The S&P/ASX200 closed up Tuesday, gaining 30 points or 0.4% to 7,535, the energy names rising on Hurricane Ida shutdowns, while tech and Industrial stocks drove the Tuesday gains. It was the best of times for the health sector: Clinuvel Pharmaceuticals (CUV) up 10% and the worst of times, Mesoblast (MSB) down 15%, the latter on an actionless and underwhelming full year. And in the perfect snippet of the earnings season that just was: profits jumped around 75% at Harvey Norman, driving a final fully-franked dividend of 35 cents. The share price down about 3.5%. That's it. The season has been reported.
Our top three VODs:
Hot off the press stock tips | the trade
John's key reporting season calls: IAG, EML
Reporting season report card: a solid B+ from Ords
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By ausbizThe S&P/ASX200 closed up Tuesday, gaining 30 points or 0.4% to 7,535, the energy names rising on Hurricane Ida shutdowns, while tech and Industrial stocks drove the Tuesday gains. It was the best of times for the health sector: Clinuvel Pharmaceuticals (CUV) up 10% and the worst of times, Mesoblast (MSB) down 15%, the latter on an actionless and underwhelming full year. And in the perfect snippet of the earnings season that just was: profits jumped around 75% at Harvey Norman, driving a final fully-franked dividend of 35 cents. The share price down about 3.5%. That's it. The season has been reported.
Our top three VODs:
Hot off the press stock tips | the trade
John's key reporting season calls: IAG, EML
Reporting season report card: a solid B+ from Ords
Hosted on Acast. See acast.com/privacy for more information.
9 Listeners
94 Listeners
14 Listeners
47 Listeners
63 Listeners
13 Listeners
8 Listeners
17 Listeners
3 Listeners
7 Listeners
10 Listeners
26 Listeners
37 Listeners
18 Listeners
4 Listeners